TMCI earnings / call / takeaways

TMCI Q3 FY26 earnings call: key takeaways

What TMCI said on its earnings call of November 6, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.

By Lician·November 6, 2026·AI-generated from the call transcript and Lician data

The company reported revenue of $48.3 million, which is above the $47.71 million consensus estimate (23:36)
The company narrowed its full year 2026 revenue guidance to $206 million to $210 million. The main message of the call was the company's focus on expanding its product portfolio and increasing market share. (12:15)

Results vs expectations

Metric	Consensus	Reported	Result
EPS	-$0.25	–	–
Revenue	$47.7M	–	–

What changed since last quarter

The company narrowed its full year 2026 revenue guidance to $206 million to $210 million, up from $204 million to $212 million. (12:15)
The company expects to return to revenue growth in the fourth quarter through procedure volume increases. (23:36)
The company introduced new products that are expected to expand its total addressable market by $700 million. (12:15)

Guidance

Metric	This call	Previous call
Revenue	Full-year 2026 revenue of $206 million to $210 million (12:15)	not captured
EBITDA	Full-year 2026 adjusted EBITDA loss of $1 million to $2 million (23:36)	not captured

What analysts pressed on

Whether the ASP mix shift dynamics will impact revenue growth in the fourth quarter. (27:08)
How the company will manage the phasing of new products during the busy bunion season. (29:17)
The potential impact of economic concerns on consumer health and interest in foot and ankle procedures. (34:49)

In their words

We're encouraged by our third quarter performance, driven by double-digit case volume growth... John Treace (12:15)
We believe this approach positions us to enhance our growth trajectory while improving operating performance over time. John Treace (12:15)
We anticipate full commercialization of this new system within Q1 of 2027. John Treace (22:25)

Read the full transcript with the AI summary, or listen on the company's official webcast.

Every past call in full and transcript search come with Lician Pro.

Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.